Skip to main content
INVENTISBIO CO., LIMITED. logo

INVENTISBIO CO., LIMITED. — Investor Relations & Filings

Ticker · 688382 ISIN · CNE100005Q22 Shanghai Stock Exchange Professional, scientific and technical activities
Open in API
Filings indexed 445 across all filing types
Latest filing 2025-06-20 Regulatory Filings
Country CN China
Listing Shanghai Stock Exchange 688382

About INVENTISBIO CO., LIMITED.

https://www.inventisbio.com/

InventisBio Co., Ltd. is a clinical-stage biopharmaceutical company dedicated to the discovery and development of innovative small molecule therapeutics. The company focuses on addressing unmet medical needs in oncology and metabolic diseases. Its research and development pipeline includes several high-potential candidates, such as befotertinib, a third-generation EGFR tyrosine kinase inhibitor for non-small cell lung cancer, and garsorasib, a potent KRAS G12C inhibitor. Additionally, the company is developing D-0502, an oral selective estrogen receptor degrader for breast cancer, and D-0120, a selective URAT1 inhibitor for the treatment of hyperuricemia and gout. InventisBio leverages its proprietary drug discovery platform and global clinical development expertise to advance a diverse portfolio of targeted therapies aimed at improving patient outcomes through precision medicine.

Recent filings

Filing Released Lang Actions
君合律师事务所上海分所关于益方生物科技（上海）股份有限公司2024年年度股东大会的法律意见书
Regulatory Filings Classification · 35% confidence The document is a legal opinion (“法律意见书”) issued by a law firm on the convening and conduct of the 2024 annual general meeting, certifying procedural compliance, attendee qualifications, voting process and results. It is not the AGM presentation materials (AGM-R), nor a pure vote-results announcement (DVA) or formal meeting notice, but rather a compliance/legal certification filed with the company’s resolutions. It thus falls into the fallback category for miscellaneous regulatory/compliance filings (RNS).
2025-06-20 Chinese
益方生物2024年年度股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled as a "2024年年度股东大会决议公告" which translates to "2024 Annual General Meeting Resolution Announcement." It details the date and location of the AGM, attendance, voting results on various proposals including the annual report, financial statements, profit distribution, and board remuneration. It also includes legal witness statements confirming the legality and validity of the meeting and resolutions. The document is a formal announcement of the voting results and resolutions passed at the AGM, not the full annual report or financial statements themselves. The length is 4435 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, this document fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2025-06-20 Chinese
益方生物2024年年度股东大会会议资料
AGM Information Classification · 100% confidence The document is titled as the "2024 Annual General Meeting (AGM) materials" for Yifang Bio-Technology (Shanghai) Co., Ltd. It contains detailed agenda items for the 2024 AGM, including reports such as the 2024 Board of Directors Work Report, 2024 Supervisory Board Work Report, 2024 Annual Report and Summary, 2024 Financial Final Accounts Report, 2025 Financial Budget Report, profit distribution plan, and remuneration proposals for 2025. The document includes meeting procedures, voting rules, and attachments of the reports to be discussed at the AGM. The content is consistent with materials prepared and distributed for an Annual General Meeting to inform shareholders and facilitate voting on key company matters. It is not the annual report itself, nor a voting results announcement, but the meeting materials for the AGM. Therefore, the document fits the category of AGM Information (AGM-R). The document length (15,000 characters) and detailed content confirm it is the meeting materials, not a brief announcement or a report publication notice.
2025-06-12 Chinese
益方生物关于召开2024年年度股东大会的通知
AGM Information Classification · 100% confidence The document is a detailed notice about the convening of the 2024 Annual General Meeting (AGM) of the company, including the date, voting methods, agenda items, and procedural details. It does not contain the actual annual report or financial statements but rather the announcement and information related to the AGM itself. The document length is about 4015 characters, which is relatively short and consistent with an announcement rather than a full report. The content focuses on meeting logistics, agenda, and voting instructions, which aligns with the definition of AGM Information (AGM-R).
2025-05-30 Chinese
益方生物科技（上海）股份有限公司章程（2025年5月修订）
Governance Information Classification · 95% confidence The document is a detailed company charter or articles of association for 益方生物科技（上海）股份有限公司 (InventisBio Co., Limited). It includes chapters on general provisions, business scope, shares issuance and transfer, shareholders and shareholders' meetings, board of directors, senior management, financial accounting system, profit distribution, audit, notices and announcements, mergers, capital changes, dissolution, liquidation, and amendments to the charter. The content is legal and governance-related, focusing on company structure, shareholder rights, board responsibilities, and corporate governance rules. There is no financial performance data, earnings information, or audit report results. It is not a report of financial results or an announcement of voting results. It is a governance document outlining internal rules and governance practices of the company. Therefore, the appropriate classification is Governance Information (CGR). The document length (15,000 characters) and detailed content support this classification with high confidence.
2025-05-30 Chinese
益方生物关于取消监事会、变更公司注册资本并修订《公司章程》及部分治理制度的公告
Governance Information Classification · 95% confidence The document is a detailed announcement from a company (益方生物科技（上海）股份有限公司) regarding significant corporate governance changes, including the cancellation of the supervisory board, changes to the company's registered capital, and revisions to the company's articles of association and governance rules. It includes detailed legal and regulatory references, amendments to the company charter, and governance procedures. The document is not a financial report, earnings release, or audit report, nor is it a simple announcement of a report publication. It is a formal announcement of changes in the company's governance structure and internal rules, which fits the category of Governance Information (CGR). The length and detail confirm it is the actual governance document, not just a notice or summary. Therefore, the appropriate classification is Governance Information (CGR) with high confidence.
2025-05-30 Chinese

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.